MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2018 International Congress

October 5-9, 2018. Hong Kong. Abstracts are presented on the 6th, 7th, and 8th.

View by Title View Sessions
View by Date

Saturday, October 6, 2018

1:45pm-3:15pm
Variation in the L-dopa motor response in pathologically confirmed Parkinson’s disease

V. Pitz, N. Malek, K. Grosset, D. Grosset (Glasgow, United Kingdom)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG
1:45pm-3:15pm
VIT-D and Tics Movement Disorder

N. Gemawat (Mumbai, India)

Pediatric Movement Disorders  ·  Hall 3FG
1:45pm-3:15pm
Vitamin B3 and Neurodevelopment in Parkinson’s Disease

A. Williams, S. Griffin, R. Fricker (Birmingham, United Kingdom)

Therapy in Movement Disorders: Gene and Cell-Based Therapies  ·  Hall 3FG
1:45pm-3:15pm
VY-AADC01 gene therapy in Parkinson’s disease: Interim results of the on-going Phase 1b PD-1101 trial

P. Larson, K. Bankiewicz, A. Van Laar, R. Richardson, B. Ravina, A. Kells, B. Boot, A. Martin, M. Thompson, C. Christine (San Francisco, CA, USA)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG
1:45pm-3:15pm
Weight loss and nutritional status in Parkinson’s disease patients under levodopa/carbidopa intestinal gel infusion treatment

M. Fabbri, M. Zibetti, L. Beccaria, A. Romagnolo, E. Montanaro, J. Ferreira, L. Lopiano (Lisbon, Portugal)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG
1:45pm-3:15pm
Weight loss in STN DBS in Parkinson’s Disease? Long-term outcome of a prospective cohort at 5 years

D. Chan, C. Chan, A. Chan, C. Lau, C. Zhu, W. Poon, V. Mok (Hong Kong, Hong Kong)

Surgical Therapy: Parkinson's Disease  ·  Hall 3FG
1:45pm-3:15pm
Weight variation in Parkinson’s disease patients treated with levodopa-carbidopa intestinal gel infusion

B. Fernández-Rodríguez, J. Dupouy, E. Harroch, MH. Fabre-Delcros, C. Barthélémy, P. Loubière, K. Barange, C. Brefel-Courbon, O. Rascol, F. Ory-Magne (Toulouse, France)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG
1:45pm-3:15pm
What is the relationship between dyskinesia and performance of activities of daily living in patients with Parkinson’s disease?

E. Goubault, S. Bogard, K. Lebel, C. Duval (Montreal, QC, Canada)

Drug-Induced Movement Disorders  ·  Hall 3FG
1:45pm-3:15pm
What makes a successful Phase 2 study: An evaluation of Parkinson’s neuroprotective trial design over the last 5 years

T. Dominey, S. Buff, G. Rafaloff, C. Carroll (Plymouth, United Kingdom)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG
1:45pm-3:15pm
Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture

J. Ferrario, A. Bernardi, P. Ballestero, M. Ferrario, M. Schenk, E. Avale, S. Guerrero, O. Gershanik (Buenos Aires, Argentina)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG
  • «Previous Page
  • 1
  • …
  • 56
  • 57
  • 58
  • 59
  • Next Page»

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley